Photo from wikipedia
Immune checkpoint inhibitors (ICIs) have been considered as novel therapeutic approaches for various cancers. ICIs were reportedly efficacious against rare cancers, including salivary gland carcinoma (SGC). We aimed to analyze… Click to show full abstract
Immune checkpoint inhibitors (ICIs) have been considered as novel therapeutic approaches for various cancers. ICIs were reportedly efficacious against rare cancers, including salivary gland carcinoma (SGC). We aimed to analyze the efficacy and safety of ICIs in patients with SGC.
Keywords:
gland carcinoma;
efficacy inhibitors;
salivary gland
Journal Title: Laryngoscope Investigative Otolaryngology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Laryngoscope Investigative Otolaryngology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!